Usefulness of midodrine in protein-losing enteropathy

J Heart Lung Transplant. 2019 Jul;38(7):784-787. doi: 10.1016/j.healun.2019.04.002. Epub 2019 Apr 15.

Authors

Angela J Weingarten¹, Jonathan N Menachem², Clayton A Smith³, Benjamin P Frischhertz¹, Wendy M Book³

Affiliations

¹ Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN; Department of Pediatrics, Division of Pediatric Cardiology, Vanderbilt, University Medical Center, Nashville, TN.
² Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, TN.
³ Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, GA.

PMID: 31031017
DOI: 10.1016/j.healun.2019.04.002

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adrenergic alpha-1 Receptor Agonists / therapeutic use*
Adult
Child
Female
Humans
Male
Midodrine / therapeutic use*
Protein-Losing Enteropathies / drug therapy*
Treatment Outcome
Young Adult

Substances

Adrenergic alpha-1 Receptor Agonists
Midodrine